| imunexus |
| https://imunexus.com Direct contact link Imunexus technology facilitates rapid cost-effective lower risk generation of effective therapeutics by converting existing monoclonal antibodies into multispecifics with additional therapeutic utility.  in**@imunexus.com |  |
For a limited time, sign up to our Starter Plan for $4.99 a month to unhide all information about the company.